• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

倒置生长模式对膀胱低级别非浸润性乳头状尿路上皮癌患者复发的影响。

The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder.

机构信息

Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey.

Clinic of Pathology, Mardin State Hospital, Mardin, Turkey.

出版信息

Balkan Med J. 2017 Sep 29;34(5):464-468. doi: 10.4274/balkanmedj.2017.0081. Epub 2017 Apr 13.

DOI:10.4274/balkanmedj.2017.0081
PMID:28443589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5635635/
Abstract

AIMS

To evaluate the impact of a histologically inverted pattern on recurrence in patients with newly diagnosed non-invasive, low-grade papillary urothelial carcinoma of the urinary bladder.

METHODS

A total of 81 patients with primary bladder non-invasive, low-grade papillary urothelial carcinoma diagnosed in a single tertiary-care centre who had at least 1-year follow-up after an initial resection were included. All slides from each case were reviewed to determine the growth pattern (exophytic versus endophytic, i.e. inverted) and other histological parameters. Clinical data were retrieved from hospital records.

RESULTS

Disease recurrence occurred in 41 (50.6%) patients. Cases with an inverted pattern showed a lower recurrence rate than those with pure exophytic tumours (37.5% versus 52.1%), a longer time to first recurrence (mean 34 versus 21.5 months) and fewer recurrence episodes (p=0.482, 0.564 and 0.051, respectively). All recurring inverted cases recurred only once during follow-up. No tumour with >80% inverted architecture recurred.

CONCLUSION

Our results suggest that non-invasive, low-grade papillary urothelial carcinoma of the bladder tends to have a better outcome in terms of disease recurrence if it shows an inverted growth pattern. To indicate the presence and percentage of the inverted pattern in low-grade urothelial carcinomas in the pathology report might be considered as an adjunct to help long-term patient management.

摘要

目的

评估新诊断的非浸润性、低级别膀胱尿路上皮乳头状癌患者中组织学倒置模式对复发的影响。

方法

共纳入 81 例在单一三级保健中心诊断为原发性膀胱非浸润性、低级别尿路上皮乳头状癌的患者,这些患者在初次切除后至少有 1 年的随访。对每个病例的所有切片进行评估,以确定生长模式(外生性与内生性,即倒置)和其他组织学参数。临床数据从医院记录中检索。

结果

41 例(50.6%)患者出现疾病复发。倒置模式的病例复发率低于纯外生性肿瘤(37.5%比 52.1%),首次复发时间更长(平均 34 比 21.5 个月),复发次数更少(p=0.482、0.564 和 0.051)。所有复发的倒置病例在随访期间仅复发一次。没有 >80%倒置结构的肿瘤复发。

结论

我们的结果表明,如果膀胱非浸润性、低级别尿路上皮乳头状癌显示倒置生长模式,其疾病复发的预后较好。病理报告中指出低级别尿路上皮癌中倒置模式的存在和百分比可能被认为是辅助长期患者管理的一种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6367/5635635/71d8c022dd70/BMJ-34-464-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6367/5635635/71d8c022dd70/BMJ-34-464-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6367/5635635/71d8c022dd70/BMJ-34-464-g3.jpg

相似文献

1
The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder.倒置生长模式对膀胱低级别非浸润性乳头状尿路上皮癌患者复发的影响。
Balkan Med J. 2017 Sep 29;34(5):464-468. doi: 10.4274/balkanmedj.2017.0081. Epub 2017 Apr 13.
2
Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.原发性低恶性潜能乳头状尿路上皮肿瘤(PUNLMP)的长期预后,包括具有内翻性生长的PUNLMP。
Diagn Pathol. 2015 Mar 13;10:3. doi: 10.1186/s13000-015-0234-z.
3
[Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].[具有内生性生长模式的尿路上皮增生性病变:一项临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):319-23.
4
Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center.膀胱低级别尿路上皮乳头状肿瘤:单中心的临床病理和结局分析。
Hum Pathol. 2011 Nov;42(11):1799-803. doi: 10.1016/j.humpath.2011.03.006.
5
Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.膀胱低级别非浸润性乳头状尿路上皮癌中微小高级别成分的意义
Hum Pathol. 2016 Jan;47(1):20-5. doi: 10.1016/j.humpath.2015.09.007. Epub 2015 Sep 25.
6
Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.经尿道切除术后 T1 期膀胱尿路上皮癌的亚分期对预后的意义。
Am J Surg Pathol. 2012 Mar;36(3):454-61. doi: 10.1097/PAS.0b013e31823dafd3.
7
Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.低恶性潜能原发性非浸润性乳头状尿路上皮肿瘤及膀胱低级别尿路上皮癌及其相关正常尿路上皮中9q32 - 33(DBC1基因座)的杂合性缺失。
J Pathol. 2008 Jul;215(3):263-72. doi: 10.1002/path.2353.
8
Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: Reclassification by international consultation on urologic disease (ICUD) recommendations.60 例具有倒置生长模式的尿路上皮肿瘤的临床病理研究:根据国际泌尿疾病咨询委员会 (ICUD) 建议进行的重新分类。
Ann Diagn Pathol. 2020 Feb;44:151433. doi: 10.1016/j.anndiagpath.2019.151433. Epub 2019 Nov 22.
9
Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.免疫组织化学染色 PTEN 表达减少与非浸润性低级别乳头状膀胱尿路上皮癌的更高进展率和复发频率相关。
Virchows Arch. 2018 Jun;472(6):969-974. doi: 10.1007/s00428-018-2302-8. Epub 2018 Jan 24.
10
Clinicopathologic Features of Noninvasive Inverted Urothelial Papillary Tumor.非浸润性倒置性尿路上皮乳头状肿瘤的临床病理特征。
Am J Clin Oncol. 2023 Sep 1;46(9):409-413. doi: 10.1097/COC.0000000000001027. Epub 2023 Jun 28.

引用本文的文献

1
Case of inverted papillary urothelial carcinoma in the ureter.输尿管内翻性乳头状尿路上皮癌病例。
IJU Case Rep. 2021 Dec 2;5(2):95-98. doi: 10.1002/iju5.12403. eCollection 2022 Mar.
2
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern.具有内翻生长模式的尿路上皮癌的独特形态学和分子特征。
J Pathol Transl Med. 2021 Jul;55(4):239-246. doi: 10.4132/jptm.2021.04.20. Epub 2021 Jun 14.

本文引用的文献

1
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.EAU 指南:非肌层浸润性膀胱尿路上皮癌:2016 年更新版。
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
2
Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.原发性低恶性潜能乳头状尿路上皮肿瘤(PUNLMP)的长期预后,包括具有内翻性生长的PUNLMP。
Diagn Pathol. 2015 Mar 13;10:3. doi: 10.1186/s13000-015-0234-z.
3
Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder.
肿瘤大小对膀胱Ta/T1期癌复发和进展的影响。
Scand J Urol Nephrol. 2011 Dec;45(6):388-92. doi: 10.3109/00365599.2011.590995. Epub 2011 Jun 16.
4
Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.无原位癌伴发的膀胱浅表性移行细胞癌膀胱内复发预测因素分析
Int J Urol. 2006 Nov;13(11):1389-92. doi: 10.1111/j.1442-2042.2006.01562.x.
5
The management of superficial transitional cell carcinoma of the bladder.膀胱浅表性移行细胞癌的管理
Urology. 2006 Mar;67(3 Suppl 1):48-54; discussion 54-5. doi: 10.1016/j.urology.2006.01.041.
6
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.使用欧洲癌症研究与治疗组织(EORTC)风险表预测Ta T1期膀胱癌个体患者的复发和进展:来自七项EORTC试验的2596例患者的综合分析
Eur Urol. 2006 Mar;49(3):466-5; discussion 475-7. doi: 10.1016/j.eururo.2005.12.031. Epub 2006 Jan 17.
7
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm.门诊电灼术治疗直径小于0.5厘米的复发性低级别乳头状膀胱肿瘤的疗效
J Urol. 2004 Feb;171(2 Pt 1):636-9. doi: 10.1097/01.ju.0000103100.22951.5e.
8
Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder.膀胱原发性Ta1级移行细胞癌的长期随访
J Urol. 1999 Dec;162(6):1946-50. doi: 10.1016/S0022-5347(05)68075-5.
9
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.上尿路移行细胞癌的预后因素、复发及生存情况:252例患者的30年经验
Urology. 1998 Oct;52(4):594-601. doi: 10.1016/s0090-4295(98)00295-7.
10
The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index.原发性Ta和T1期膀胱癌的早期临床病程:一项拟议的预后指数。
Br J Urol. 1998 May;81(5):692-8. doi: 10.1046/j.1464-410x.1998.00628.x.